TY - JOUR AU - Croft, Ashley M. AU - Herxheimer, Andrew PY - 2002 DA - 2002/03/25 TI - Adverse effects of the antimalaria drug, mefloquine: due to primary liver damage with secondary thyroid involvement? JO - BMC Public Health SP - 6 VL - 2 IS - 1 AB - Mefloquine is a clinically important antimalaria drug, which is often not well tolerated. We critically reviewed 516 published case reports of mefloquine adverse effects, to clarify the phenomenology of the harms associated with mefloquine, and to make recommendations for safer prescribing. SN - 1471-2458 UR - https://doi.org/10.1186/1471-2458-2-6 DO - 10.1186/1471-2458-2-6 ID - Croft2002 ER -